Taro Pharmaceuticals to Acquire Antibe Therapeutics

Taro Pharmaceuticals Inc., a subsidiary of Sun Pharmaceutical Industries Ltd., has reached an agreement to acquire hundred percent of Antibe Therapeutics Inc., a Canadian biotechnology firm.

About Antibe Therapeutics

Antibe Therapeutics, based in Ontario, is a clinical-stage biotechnology company founded in 2009.

Taro Pharmaceuticals focuses on developing innovative drugs aimed at reducing pain and inflammation.

However, Antibe has not reported any revenue from operations over the past three years, as confirmed by Sun Pharma in a statement to the Bombay Stock Exchange.

Transaction Details and Conditions

The acquisition is subject to a ‘reverse vesting order’ and requires approval from the Ontario Superior Court of Justice (Commercial List). Sun Pharma anticipates that the transaction will be finalized before March 7, 2025.

Funding and Disclosure Information

As reported by thehindubusinessline.com, the Ontario court is overseeing the divestment of Antibe. The court-appointed receiver has stated that the acquisition consideration will not be disclosed. This will occur only after the deal is closed.

Related Posts

  • Pharma
  • July 16, 2025
  • 126 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 40 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.